The Library
Inactivation of the antibacterial and cytotoxic properties of silver ions by biologically relevant compounds
Tools
Tools
Tools
Mulley, Geraldine, Jenkins, A. Tobias A. and Waterfield, Nicholas R. (2014) Inactivation of the antibacterial and cytotoxic properties of silver ions by biologically relevant compounds. PLoS One, Volume 9 (Number 4). Article number e94409. doi:10.1371/journal.pone.0094409
|
PDF
WRAP_Waterfield_journal.pone.0094409.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution. Download (2333Kb) | Preview |
Official URL: http://dx.doi.org/10.1371/journal.pone.0094409
Abstract
There has been a recent surge in the use of silver as an antimicrobial agent in a wide range of domestic and clinical products, intended to prevent or treat bacterial infections and reduce bacterial colonization of surfaces. It has been reported that the antibacterial and cytotoxic properties of silver are affected by the assay conditions, particularly the type of growth media used in vitro. The toxicity of Ag+ to bacterial cells is comparable to that of human cells. We demonstrate that biologically relevant compounds such as glutathione, cysteine and human blood components significantly reduce the toxicity of silver ions to clinically relevant pathogenic bacteria and primary human dermal fibroblasts (skin cells). Bacteria are able to grow normally in the presence of silver nitrate at >20-fold the minimum inhibitory concentration (MIC) if Ag+ and thiols are added in a 1:1 ratio because the reaction of Ag+ with extracellular thiols prevents silver ions from interacting with cells. Extracellular thiols and human serum also significantly reduce the antimicrobial activity of silver wound dressings Aquacel-Ag (Convatec) and Acticoat (Smith & Nephew) to Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli in vitro. These results have important implications for the deployment of silver as an antimicrobial agent in environments exposed to biological tissue or secretions. Significant amounts of money and effort have been directed at the development of silver-coated medical devices (e.g. dressings, catheters, implants). We believe our findings are essential for the effective design and testing of antimicrobial silver coatings.
| Item Type: | Journal Article | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Subjects: | R Medicine > RM Therapeutics. Pharmacology | ||||||||
| Divisions: | Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Microbiology & Infection Faculty of Medicine > Warwick Medical School |
||||||||
| Library of Congress Subject Headings (LCSH): | Silver -- Therapeutic use, Silver -- Physiological effect, Anti-infective agents | ||||||||
| Journal or Publication Title: | PLoS One | ||||||||
| Publisher: | Public Library of Science | ||||||||
| ISSN: | 1932-6203 | ||||||||
| Official Date: | 11 April 2014 | ||||||||
| Dates: |
|
||||||||
| Date of first compliant deposit: | 26 December 2015 | ||||||||
| Volume: | Volume 9 | ||||||||
| Number: | Number 4 | ||||||||
| Number of Pages: | 9 | ||||||||
| Article Number: | Article number e94409 | ||||||||
| DOI: | 10.1371/journal.pone.0094409 | ||||||||
| Status: | Peer Reviewed | ||||||||
| Publication Status: | Published | ||||||||
| Access rights to Published version: | Open Access | ||||||||
| Funder: | Seventh Framework Programme (European Commission) (FP7) | ||||||||
| Grant number: | #211436 (FP7) |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
